BRIEF-Bristol-Myers Squibb Receives FDA Approval For Opdivo As Treatment For Patients With A Type Of Skin Cancer

News

Cosmetics / News 70 Views 0

Dec 20 (Reuters) - Bristol-Myers Squibb Co: * BRISTOL-MYERS SQUIBB RECEIVES FDA APPROVAL FOR OPDIVO (NIVOLUMAB) AS ADJUVANT THERAPY IN PATIENTS WITH COMPLETELY RESECTED MELANOMA WITH LYMPH NODE INVOLVEMENT OR METASTATIC DISEASE Source text for Eikon: …

Comments